These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 17015828)
21. Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia. Gandemer V; Rio AG; de Tayrac M; Sibut V; Mottier S; Ly Sunnaram B; Henry C; Monnier A; Berthou C; Le Gall E; Le Treut A; Schmitt C; Le Gall JY; Mosser J; Galibert MD BMC Genomics; 2007 Oct; 8():385. PubMed ID: 17956600 [TBL] [Abstract][Full Text] [Related]
22. [Prognostic significance of TEL/AML1 rearrangement and its additional genetic changes in Korean childhood precursor B-acute lymphoblastic leukemia]. Chung HY; Kim KH; Jun KR; Jang S; Park CJ; Chi HS; Im HJ; Seo JJ; Seo EJ Korean J Lab Med; 2010 Feb; 30(1):1-8. PubMed ID: 20197715 [TBL] [Abstract][Full Text] [Related]
24. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299 [TBL] [Abstract][Full Text] [Related]
25. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia. Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496 [TBL] [Abstract][Full Text] [Related]
26. Detection of concurrent TEL-AML1/TEL-ABL fusion genes in a patient with B-acute lymphoblastic leukemia using a multi-fusion gene qRT-PCR screening method. Zhang J; Mao S; Su S; Wei L; Li T; Liu Y Pathol Int; 2016 Aug; 66(8):475-7. PubMed ID: 27418307 [No Abstract] [Full Text] [Related]
27. Infection Exposure Promotes Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052 [No Abstract] [Full Text] [Related]
28. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Schindler JW; Van Buren D; Foudi A; Krejci O; Qin J; Orkin SH; Hock H Cell Stem Cell; 2009 Jul; 5(1):43-53. PubMed ID: 19570513 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China. Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709 [TBL] [Abstract][Full Text] [Related]
31. TEL/AML1 and immunoreceptor gene rearrangements-which comes first? Zuna J; Krejci O; Madzo J; Fronkova E; Sramkova L; Hrusak O; Kalina T; Vaskova M; Stary J; Trka J; Leuk Res; 2005 Jun; 29(6):633-9. PubMed ID: 15863202 [TBL] [Abstract][Full Text] [Related]
32. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750 [TBL] [Abstract][Full Text] [Related]
34. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Zelent A; Greaves M; Enver T Oncogene; 2004 May; 23(24):4275-83. PubMed ID: 15156184 [TBL] [Abstract][Full Text] [Related]
36. Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report. Park JE; Park IJ; Lim YA; Lee WG; Cho SR Ann Clin Lab Sci; 2013; 43(2):186-9. PubMed ID: 23694795 [TBL] [Abstract][Full Text] [Related]
37. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study. Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518 [TBL] [Abstract][Full Text] [Related]
38. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases. Zaliova M; Meyer C; Cario G; Vaskova M; Marschalek R; Stary J; Zuna J; Trka J Pediatr Blood Cancer; 2011 Feb; 56(2):217-25. PubMed ID: 21157892 [TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic. Hrusák O; Trka J; Zuna J; Housková J; Bartůnková J; Starý J Leukemia; 1998 Jul; 12(7):1064-70. PubMed ID: 9665191 [TBL] [Abstract][Full Text] [Related]
40. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies]. Zuna J Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]